$CRDF
Cardiff Oncology, Inc. Stock $crdf

$crdf Overview Financials Valuation SEC Filings Company Website

2015 Form 10-K Financial Statement

#000162828016012562 Filed on March 10, 2016

Income Statement

Concept	2015	2014 Q4	2014 Q3
Revenue	$312.8K	$56.00K	$57.00K
YoY Change	11.65%	19.15%	29.55%
Cost Of Revenue	$629.2K	$20.00K	$0.00
YoY Change	3974.81%
Gross Profit	-$316.4K	$40.00K	$57.00K
YoY Change	-219.51%
Gross Profit Margin	-101.14%	71.43%	100.0%
Selling, General & Admin	$14.36M	$3.570M	$2.007M
YoY Change	68.09%	91.94%	-9.18%
% of Gross Profit		8925.0%	3521.36%
Research & Development	$10.59M	$970.0K	$1.990M
YoY Change	58.95%	-6.73%	117.41%
% of Gross Profit		2425.0%	3491.67%
Depreciation & Amortization	$378.7K	$60.00K	$60.00K
YoY Change	61.28%	50.0%	20.0%
% of Gross Profit		150.0%	105.26%
Operating Expenses	$25.59M	$4.560M	$3.997M
YoY Change	68.05%	57.24%	336.61%
Operating Profit	-$25.27M	-$4.520M	-$3.940M
YoY Change	69.11%		28.03%
Interest Expense	$1.525M	-$180.0K	$389.9K
YoY Change	80.9%	-109.78%	6124.99%
% of Operating Profit
Other Income/Expense, Net	$0.00	-$20.00K	-$19.26K
YoY Change
Pretax Income	-$27.47M	-$4.680M	-$5.380M
YoY Change	91.7%	354.37%	22.27%
Income Tax	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$27.47M	-$4.680M	-$5.375M
YoY Change	91.76%	354.37%	22.13%
Net Earnings / Revenue	-8781.98%	-8357.14%	-9430.21%
Basic Earnings Per Share	-$1.05	-$0.25	-$0.28
Diluted Earnings Per Share	-$1.21	-$0.25	-$0.28
COMMON SHARES
Basic Shares Outstanding	26.20M shares	18.90M shares	18.90M shares
Diluted Shares Outstanding	26.45M shares	19.07M shares	18.90M shares

Balance Sheet

Concept	2015	2014 Q4	2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$67.50M	$27.30M	$31.20M
YoY Change	147.25%	5.81%	12.23%
Cash & Equivalents	$67.50M	$67.49M	$31.16M
Short-Term Investments
Other Short-Term Assets	$800.0K	$400.0K	$300.0K
YoY Change	100.0%	100.0%	200.0%
Inventory
Prepaid Expenses
Receivables	$100.0K	$56.69K	$100.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$68.40M	$27.72M	$31.60M
YoY Change	146.93%	6.33%	12.86%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.700M	$840.4K	$800.0K
YoY Change	237.5%	11.97%	8.06%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$400.0K	$336.7K	$300.0K
YoY Change	33.33%	0.08%	-27.17%
Total Long-Term Assets	$3.000M	$1.177M	$1.200M
YoY Change	150.0%	8.29%	4.15%
TOTAL ASSETS
Total Short-Term Assets	$68.40M	$27.72M	$31.60M
Total Long-Term Assets	$3.000M	$1.177M	$1.200M
Total Assets	$71.40M	$28.90M	$32.80M
YoY Change	147.06%	6.41%	12.52%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.000M	$747.8K	$500.0K
YoY Change	42.86%	160.91%	214.5%
Accrued Expenses	$1.900M	$1.842M	$1.900M
YoY Change	5.56%	20.85%	80.25%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$5.200M	$1.900M	$800.0K
YoY Change	173.68%	850.0%	700.0%
Total Short-Term Liabilities	$8.200M	$4.488M	$3.100M
YoY Change	82.22%	123.42%	127.82%
LONG-TERM LIABILITIES
Long-Term Debt	$11.20M	$13.10M	$14.00M
YoY Change	-14.5%	4266.67%	3400.0%
Other Long-Term Liabilities	$3.300M	$3.000M	$3.300M
YoY Change	10.0%	-31.82%	-47.62%
Total Long-Term Liabilities	$14.50M	$16.10M	$17.30M
YoY Change	-9.94%	242.55%	158.21%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.200M	$4.488M	$3.100M
Total Long-Term Liabilities	$14.50M	$16.10M	$17.30M
Total Liabilities	$22.70M	$20.55M	$20.40M
YoY Change	10.73%	203.79%	154.61%
SHAREHOLDERS EQUITY
Retained Earnings		-$81.39M
YoY Change		21.4%
Common Stock		$1.891K
YoY Change		0.05%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$48.70M	$8.350M	$12.40M
YoY Change
Total Liabilities & Shareholders Equity	$71.40M	$28.90M	$32.80M
YoY Change	147.06%	6.41%	12.52%

Cashflow Statement

Concept	2015	2014 Q4	2014 Q3
OPERATING ACTIVITIES
Net Income	-$27.47M	-$4.680M	-$5.375M
YoY Change	91.76%	354.37%	22.13%
Depreciation, Depletion And Amortization	$378.7K	$60.00K	$60.00K
YoY Change	61.28%	50.0%	20.0%
Cash From Operating Activities	-$22.12M	-$3.870M	-$3.410M
YoY Change	73.76%	108.06%	62.38%
INVESTING ACTIVITIES
Capital Expenditures	$2.241M	-$120.0K	-$110.0K
YoY Change	516.88%	50.0%	-47.62%
Acquisitions
YoY Change
Other Investing Activities	$10.00K	$60.00K
YoY Change	-83.33%
Cash From Investing Activities	-$2.230M	-$60.00K	-$110.0K
YoY Change	643.33%	-25.0%	-47.62%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$61.22M
YoY Change
Debt Paid & Issued, Net	$0.00
YoY Change
Cash From Financing Activities	64.55M	60.00K	0.000
YoY Change	345.79%	-300.0%	-100.0%
NET CHANGE
Cash From Operating Activities	-22.12M	-3.870M	-3.410M
Cash From Investing Activities	-2.230M	-60.00K	-110.0K
Cash From Financing Activities	64.55M	60.00K	0.000
Net Change In Cash	40.20M	-3.870M	-3.520M
YoY Change	2672.41%	96.45%	-118.06%
FREE CASH FLOW
Cash From Operating Activities	-$22.12M	-$3.870M	-$3.410M
Capital Expenditures	$2.241M	-$120.0K	-$110.0K
Free Cash Flow	-$24.36M	-$3.750M	-$3.300M
YoY Change	86.06%	110.67%	74.6%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2015	dei	Amendment Flag AmendmentFlag	false
CY2015	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2015	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2015	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2015
CY2015	dei	Document Period End Date DocumentPeriodEndDate	2015-12-31
CY2015	dei	Document Type DocumentType	10-K
CY2015	dei	Entity Central Index Key EntityCentralIndexKey	0001213037
CY2016Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	29757810	shares
CY2015	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2015	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2015Q2	dei	Entity Public Float EntityPublicFloat	195681564	USD
CY2015	dei	Entity Registrant Name EntityRegistrantName	Trovagene, Inc.
CY2015	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2015	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2013	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	0	USD
CY2014	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	-2422337	USD
CY2015	trov	Adjustment For Change In Unrealized Gain Loss On Derivatives AdjustmentForChangeInUnrealizedGainLossOnDerivatives	-4396061	USD
CY2013	trov	Adjustment To Additional Paid In Capital For Warrants Issued As Noncash Consideration AdjustmentToAdditionalPaidInCapitalForWarrantsIssuedAsNoncashConsideration	198791	USD
CY2014	trov	Adjustments To Additional Paid In Capital Warrant Issued Debt Agreement AdjustmentsToAdditionalPaidInCapitalWarrantIssuedDebtAgreement	235857	USD
CY2013	trov	Adjustments To Additional Paid In Capital Warrants Reclassified Amount AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedAmount	5417871	USD
CY2015	trov	Adjustments To Additional Paid In Capital Warrants Reclassified Amount AdjustmentsToAdditionalPaidInCapitalWarrantsReclassifiedAmount	435365	USD
CY2013	trov	Adjustmentsto Additional Paidin Capital Warrants Reclassified Non Cash Portion Amount AdjustmentstoAdditionalPaidinCapitalWarrantsReclassifiedNonCashPortionAmount	5417871	USD
CY2014	trov	Adjustmentsto Additional Paidin Capital Warrants Reclassified Non Cash Portion Amount AdjustmentstoAdditionalPaidinCapitalWarrantsReclassifiedNonCashPortionAmount	0	USD
CY2015	trov	Adjustmentsto Additional Paidin Capital Warrants Reclassified Non Cash Portion Amount AdjustmentstoAdditionalPaidinCapitalWarrantsReclassifiedNonCashPortionAmount	-435365	USD
CY2015Q2	trov	Area Of Land After Expansion AreaOfLandAfterExpansion	22600	sqft
CY2015Q4	trov	Area Of Land After Expansion AreaOfLandAfterExpansion	2300	sqft
CY2013	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	728488	shares
CY2014	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	36666	shares
CY2015	trov	Class Of Warrant Or Right Number Exercised ClassOfWarrantOrRightNumberExercised	732378	shares
CY2013	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	73099	shares
CY2014	trov	Class Of Warrant Or Right Number Expired ClassOfWarrantOrRightNumberExpired	16667	shares
CY2013	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	50000	shares
CY2014	trov	Class Of Warrant Or Right Number Granted ClassOfWarrantOrRightNumberGranted	85470	shares
CY2012Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.96
CY2013Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.87
CY2014Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.85
CY2015Q4	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRights	3.86
CY2013	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	4.99
CY2014	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.00
CY2015	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Exercised ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExercised	3.77
CY2013	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	4.50
CY2014	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Expired ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsExpired	10.80
CY2013	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	8.00
CY2014	trov	Class Of Warrant Or Right Weighted Average Exercise Price Of Warrants Or Rights Granted ClassOfWarrantOrRightWeightedAverageExercisePriceOfWarrantsOrRightsGranted	3.51
CY2015	trov	Decrease In Derivative Liability Due To Exercise Of Warrants DecreaseInDerivativeLiabilityDueToExerciseOfWarrants	435365	USD
CY2014Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	698000	USD
CY2015Q4	trov	Deferred Tax Assets Tax Credit Carryforwards Research And Other DeferredTaxAssetsTaxCreditCarryforwardsResearchAndOther	1698300	USD
CY2015	trov	Defined Contribution Plan Threshold Age Catch Up Contribution DefinedContributionPlanThresholdAgeCatchUpContribution	P50Y
CY2014	trov	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	0.02
CY2015	trov	Effective Income Tax Rate Reconciliation Permanent Items EffectiveIncomeTaxRateReconciliationPermanentItems	-0.01
CY2014	trov	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	-320000	USD
CY2015	trov	Income Tax Reconciliation Permanent Items IncomeTaxReconciliationPermanentItems	258000	USD
CY2015Q2	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	60000	USD
CY2015Q4	trov	Operating Lease Monthly Rent OperatingLeaseMonthlyRent	3100	USD
CY2013Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	0	USD
CY2014Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	235857	USD
CY2015Q4	trov	Original Value Of Warrants OriginalValueOfWarrants	0	USD
CY2013	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	29840	USD
CY2014	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	23015	USD
CY2015	trov	Preferred Stock Dividend Accrued PreferredStockDividendAccrued	24240	USD
CY2013	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	198791	USD
CY2014	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	0	USD
CY2015	trov	Stock Based Expense For Consulting Services StockBasedExpenseForConsultingServices	0	USD
CY2015	trov	Term Of Extension For Interest Only Payment TermOfExtensionForInterestOnlyPayment	P6M
CY2015Q2	trov	Threshold Level Of Unrestricted Net Cash Proceeds Required To Extend Interest Only Payment Date ThresholdLevelOfUnrestrictedNetCashProceedsRequiredToExtendInterestOnlyPaymentDate	30000000	USD
CY2015Q2	trov	Threshold Level Of Unrestricted Net Cash Proceeds Required To Extend Interest Only Payment Date After Amendment ThresholdLevelOfUnrestrictedNetCashProceedsRequiredToExtendInterestOnlyPaymentDateAfterAmendment	21000000	USD
CY2013	trov	Value Of Warrants Issued During Period For Cash Consideration ValueOfWarrantsIssuedDuringPeriodForCashConsideration	3599831	USD
CY2015	trov	Value Of Warrants Issued During Period For Cash Consideration ValueOfWarrantsIssuedDuringPeriodForCashConsideration	1389427	USD
CY2012	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P5Y4M28D
CY2013	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P4Y5M23D
CY2014	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P3Y6M26D
CY2015	trov	Warrants Weighted Average Contractual Term WarrantsWeightedAverageContractualTerm	P2Y6M11D
CY2014Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	747799	USD
CY2015Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1040868	USD
CY2014Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	56694	USD
CY2015Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	98736	USD
CY2014	us-gaap	Accretion Of Discount AccretionOfDiscount	57117	USD
CY2015	us-gaap	Accretion Of Discount AccretionOfDiscount	88123	USD
CY2014Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1841808	USD
CY2015Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1934411	USD
CY2014Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	533870	USD
CY2015Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	854782	USD
CY2014Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	89739511	USD
CY2015Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	157585498	USD
CY2013	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1979364	USD
CY2014	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2070195	USD
CY2015	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3946027	USD
CY2013	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1979364	USD
CY2014	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2070194	USD
CY2015	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3946027	USD
CY2014	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	248799	USD
CY2015	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	346157	USD
CY2013	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10584153	shares
CY2014	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	10228257	shares
CY2015	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11577702	shares
CY2014Q4	us-gaap	Assets Assets	28896846	USD
CY2015Q4	us-gaap	Assets Assets	71445651	USD
CY2014Q4	us-gaap	Assets Current AssetsCurrent	27719751	USD
CY2015Q4	us-gaap	Assets Current AssetsCurrent	68381068	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10819781	USD
CY2013Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	25836937	USD
CY2014Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	27293798	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	67493047	USD
CY2012Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6985070	shares
CY2013Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6233483	shares
CY2014Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	6265620	shares
CY2015Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	5533242	shares
CY2014Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2015Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2014Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2015Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2014Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2015Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2014Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	18915793	shares
CY2015Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	29737601	shares
CY2014Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	18915793	shares
CY2015Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	29737601	shares
CY2014Q4	us-gaap	Common Stock Value CommonStockValue	1891	USD
CY2015Q4	us-gaap	Common Stock Value CommonStockValue	2974	USD
CY2014	us-gaap	Cost Of Revenue CostOfRevenue	15441	USD
CY2015	us-gaap	Cost Of Revenue CostOfRevenue	629191	USD
CY2013	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-3806000	USD
CY2014	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-5651000	USD
CY2015	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-9602000	USD
CY2013	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-4399000	USD
CY2014	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-6100000	USD
CY2015	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-11344000	USD
CY2013	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-593000	USD
CY2014	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-449000	USD
CY2015	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-1742000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	22323600	USD
CY2015Q4	us-gaap	Deferred Tax Assets Gross Current DeferredTaxAssetsGrossCurrent	33667500	USD
CY2014Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	19010900	USD
CY2015Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27962000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	420800	USD
CY2015Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	782000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2193900	USD
CY2015Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	3225200	USD
CY2013Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	4399000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	6100000	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	11344000	USD
CY2014Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	22323600	USD
CY2015Q4	us-gaap	Deferred Tax Assets Valuation Allowance Current DeferredTaxAssetsValuationAllowanceCurrent	33667500	USD
CY2014Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2015Q4	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	0	USD
CY2013	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	130520	USD
CY2014	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	234813	USD
CY2015	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	378711	USD
CY2014Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3006021	USD
CY2015Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	3297077	USD
CY2013	us-gaap	Dividends Preferred Stock DividendsPreferredStock	29840	USD
CY2014	us-gaap	Dividends Preferred Stock DividendsPreferredStock	23015	USD
CY2015	us-gaap	Dividends Preferred Stock DividendsPreferredStock	24240	USD
CY2013	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.70
CY2014Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2014Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2014Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.28
CY2014Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2014	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.76
CY2015Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
CY2015Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
CY2015Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.10
CY2015Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.25
CY2015	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.05
CY2013	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.70
CY2014Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2014Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2014Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.28
CY2014Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.25
CY2014	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.88
CY2015Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
CY2015Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
CY2015Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2015Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
CY2015	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.21
CY2014	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2015	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0
CY2014	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.35
CY2015	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.34
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.43
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.42
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.00
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Other Adjustments EffectiveIncomeTaxRateReconciliationOtherAdjustments	0.00
CY2014	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06
CY2015	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	0.06
CY2014	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.00
CY2015	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.03
CY2015	us-gaap	Employee Service Share Based Compensation Tax Benefit Realized From Exercise Of Stock Options EmployeeServiceShareBasedCompensationTaxBenefitRealizedFromExerciseOfStockOptions	0	USD
CY2013	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-22941	USD
CY2014	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	24845	USD
CY2015	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-4562	USD
CY2013	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5472038	USD
CY2014	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5810087	USD
CY2015	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	7919826	USD
CY2015	us-gaap	Income Tax Examination Penalties And Interest Expense IncomeTaxExaminationPenaltiesAndInterestExpense	0	USD
CY2013	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2015	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	USD
CY2014	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	6081000	USD
CY2015	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	11638000	USD
CY2014	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-4871000	USD
CY2015	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-9340000	USD
CY2014	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	1000	USD
CY2015	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	0	USD
CY2014	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-891000	USD
CY2015	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-1559000	USD
CY2014	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	0	USD
CY2015	us-gaap	Income Tax Reconciliation Tax Credits IncomeTaxReconciliationTaxCredits	997000	USD
CY2013	us-gaap	Income Taxes Paid IncomeTaxesPaid	7650	USD
CY2014	us-gaap	Income Taxes Paid IncomeTaxesPaid	2400	USD
CY2015	us-gaap	Income Taxes Paid IncomeTaxesPaid	16934	USD
CY2013	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1055690	USD
CY2014	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	632299	USD
CY2015	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	361432	USD
CY2013	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-89387	USD
CY2014	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22300	USD
CY2015	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	42042	USD
CY2013	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-25631	USD
CY2014	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	258	USD
CY2015	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	37296	USD
CY2013	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	92748	USD
CY2014	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	216470	USD
CY2015	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	420026	USD
CY2013	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2014	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	166832	shares
CY2015	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	250452	shares
CY2013	us-gaap	Interest Expense InterestExpense	17005	USD
CY2014	us-gaap	Interest Expense InterestExpense	843259	USD
CY2015	us-gaap	Interest Expense InterestExpense	1525482	USD
CY2013	us-gaap	Interest Paid InterestPaid	9459	USD
CY2014	us-gaap	Interest Paid InterestPaid	425256	USD
CY2015	us-gaap	Interest Paid InterestPaid	1061993	USD
CY2013	us-gaap	Investment Income Net InvestmentIncomeNet	3663	USD
CY2014	us-gaap	Investment Income Net InvestmentIncomeNet	12239	USD
CY2015	us-gaap	Investment Income Net InvestmentIncomeNet	57261	USD
CY2015Q4	us-gaap	Lessee Leasing Arrangements Operating Leases Term Of Contract LesseeLeasingArrangementsOperatingLeasesTermOfContract	P3Y
CY2014Q4	us-gaap	Liabilities Liabilities	20547293	USD
CY2015Q4	us-gaap	Liabilities Liabilities	22744362	USD
CY2014Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	28896846	USD
CY2015Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	71445651	USD
CY2014Q4	us-gaap	Liabilities Current LiabilitiesCurrent	4488155	USD
CY2015Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8201097	USD
CY2013	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
CY2014	us-gaap	License And Services Revenue LicenseAndServicesRevenue	10000	USD
CY2015	us-gaap	License And Services Revenue LicenseAndServicesRevenue	0	USD
CY2014	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-12727385	USD
CY2015Q4	us-gaap	Line Of Credit LineOfCredit	1086062	USD
CY2015Q4	us-gaap	Lines Of Credit Current LinesOfCreditCurrent	30168	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	13053117	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	11246188	USD
CY2014Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	1898548	USD
CY2015Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	5225818	USD
CY2015Q4	us-gaap	Long Term Line Of Credit LongTermLineOfCredit	1058709	USD
CY2013	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	15017156	USD
CY2014	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1456861	USD
CY2015	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	40199249	USD
CY2013	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	22983688	USD
CY2014	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	14484036	USD
CY2015	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	64551740	USD
CY2013	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-649284	USD
CY2014	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-299790	USD
CY2015	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-2233466	USD
CY2013	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-7317248	USD
CY2015	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-22119025	USD
CY2013	us-gaap	Net Income Loss NetIncomeLoss	-11810938	USD
CY2014	us-gaap	Net Income Loss NetIncomeLoss	-14325484	USD
CY2015	us-gaap	Net Income Loss NetIncomeLoss	-27471094	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-11840778	USD
CY2014Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3198000	USD
CY2014Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1079000	USD
CY2014Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-5382000	USD
CY2014Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4689000	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14348499	USD
CY2015Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7180000	USD
CY2015Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-10186000	USD
CY2015Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-2742000	USD
CY2015Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-7387000	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-27495334	USD
CY2013	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-11840778	USD
CY2014	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-16770836	USD
CY2015	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-31891395	USD
CY2013	us-gaap	Operating Expenses OperatingExpenses	10949787	USD
CY2014Q1	us-gaap	Operating Expenses OperatingExpenses	3371000	USD
CY2014Q2	us-gaap	Operating Expenses OperatingExpenses	3297000	USD
CY2014Q3	us-gaap	Operating Expenses OperatingExpenses	3997000	USD
CY2014Q4	us-gaap	Operating Expenses OperatingExpenses	4560000	USD
CY2014	us-gaap	Operating Expenses OperatingExpenses	15225337	USD
CY2015Q1	us-gaap	Operating Expenses OperatingExpenses	4975000	USD
CY2015Q2	us-gaap	Operating Expenses OperatingExpenses	6682000	USD
CY2015Q3	us-gaap	Operating Expenses OperatingExpenses	6467000	USD
CY2015Q4	us-gaap	Operating Expenses OperatingExpenses	7463000	USD
CY2015	us-gaap	Operating Expenses OperatingExpenses	25586464	USD
CY2013	us-gaap	Operating Income Loss OperatingIncomeLoss	-10690541	USD
CY2014	us-gaap	Operating Income Loss OperatingIncomeLoss	-14945159	USD
CY2015	us-gaap	Operating Income Loss OperatingIncomeLoss	-25273652	USD
CY2013	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	294000	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Three Years OperatingLeasesFutureMinimumPaymentsDueInThreeYears	811797	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	4745123	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	683871	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Five Years OperatingLeasesFutureMinimumPaymentsDueInFiveYears	817989	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Four Years OperatingLeasesFutureMinimumPaymentsDueInFourYears	796716	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	792221	USD
CY2015Q4	us-gaap	Operating Leases Future Minimum Payments Due Thereafter OperatingLeasesFutureMinimumPaymentsDueThereafter	842529	USD
CY2014	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	23015	USD
CY2015	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	24240	USD
CY2014Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2015Q4	us-gaap	Preferred Stock Liquidation Preference Value PreferredStockLiquidationPreferenceValue	606000	USD
CY2014	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	315000	USD
CY2015	us-gaap	Operating Leases Rent Expense Net OperatingLeasesRentExpenseNet	471000	USD
CY2014Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	336708	USD
CY2015Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	374004	USD
CY2013	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-22941	USD
CY2014	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	24845	USD
CY2015	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	-2800	USD
CY2013	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
CY2014	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	0	USD
CY2015	us-gaap	Other Sales Revenue Net OtherSalesRevenueNet	24375	USD
CY2013	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	649784	USD
CY2014	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	363290	USD
CY2015	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2241066	USD
CY2013	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	29840	USD
CY2014Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2015Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2014Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2015Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2014Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2015Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	60600	shares
CY2014Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2015Q4	us-gaap	Preferred Stock Value PreferredStockValue	60	USD
CY2014Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	369259	USD
CY2015Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	789285	USD
CY2013	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	18829644	USD
CY2014	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2015	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	61215399	USD
CY2013	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2014	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	15000000	USD
CY2015	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2013	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	515964	USD
CY2014	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2015	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	1086062	USD
CY2013	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	500	USD
CY2014	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	63500	USD
CY2015	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	7600	USD
CY2013	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	38249	USD
CY2014	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	USD
CY2015	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	860852	USD
CY2013	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3599831	USD
CY2014	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	USD
CY2015	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	1389427	USD
CY2014Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	1374257	USD
CY2015Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	3545361	USD
CY2014Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	840387	USD
CY2015Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2690579	USD
CY2013	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2014	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	515964	USD
CY2015	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	USD
CY2013	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	3947589	USD
CY2014	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	6664906	USD
CY2015	us-gaap	Research And Development Expense Excluding Acquired In Process Cost ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost	10593869	USD
CY2014Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-81391909	USD
CY2015Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-108887243	USD
CY2013	us-gaap	Royalty Revenue RoyaltyRevenue	259246	USD
CY2014	us-gaap	Royalty Revenue RoyaltyRevenue	270178	USD
CY2015	us-gaap	Royalty Revenue RoyaltyRevenue	274648	USD
CY2013	us-gaap	Sales Revenue Net SalesRevenueNet	259246	USD
CY2014Q1	us-gaap	Sales Revenue Net SalesRevenueNet	111000	USD
CY2014Q2	us-gaap	Sales Revenue Net SalesRevenueNet	56000	USD
CY2014Q3	us-gaap	Sales Revenue Net SalesRevenueNet	57000	USD
CY2014Q4	us-gaap	Sales Revenue Net SalesRevenueNet	56000	USD
CY2014	us-gaap	Sales Revenue Net SalesRevenueNet	280178	USD
CY2015Q1	us-gaap	Sales Revenue Net SalesRevenueNet	127000	USD
CY2015Q2	us-gaap	Sales Revenue Net SalesRevenueNet	49000	USD
CY2015Q3	us-gaap	Sales Revenue Net SalesRevenueNet	58000	USD
CY2015Q4	us-gaap	Sales Revenue Net SalesRevenueNet	79000	USD
CY2015	us-gaap	Sales Revenue Net SalesRevenueNet	312812	USD
CY2013	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	0	USD
CY2014	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	0	USD
CY2015	us-gaap	Sales Revenue Services Net SalesRevenueServicesNet	13789	USD
CY2013	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1530160	USD
CY2014	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2734903	USD
CY2015	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6443578	USD
CY2013	us-gaap	Share Based Compensation ShareBasedCompensation	1979364	USD
CY2014	us-gaap	Share Based Compensation ShareBasedCompensation	2070194	USD
CY2015	us-gaap	Share Based Compensation ShareBasedCompensation	3946027	USD
CY2013	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	275492	USD
CY2014	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	USD
CY2015	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1382255	USD
CY2013	us-gaap	Share Based Goods And Nonemployee Services Transaction Valuation Method Expected Dividend Rate ShareBasedGoodsAndNonemployeeServicesTransactionValuationMethodExpectedDividendRate	0.00
CY2013	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1633071	USD
CY2014	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1960256	USD
CY2015	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2634688	USD
CY2013	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	18829644	USD
CY2015	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	61215399	USD
CY2013	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	38249	USD
CY2015	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	860852	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	2169028	USD
CY2013Q4	us-gaap	Stockholders Equity StockholdersEquity	20392000	USD
CY2014Q4	us-gaap	Stockholders Equity StockholdersEquity	8349553	USD
CY2015Q4	us-gaap	Stockholders Equity StockholdersEquity	48701289	USD
CY2013	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-1084114	USD
CY2014	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1425850	USD
CY2015	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	-726421	USD
CY2013	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	16978212	shares
CY2014Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18902783	shares
CY2014Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19232760	shares
CY2014Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18902783	shares
CY2014Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19071112	shares
CY2014	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19071112	shares
CY2015Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	21817710	shares
CY2015Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	24592883	shares
CY2015Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	29128235	shares
CY2015Q4	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30157038	shares
CY2015	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	26452165	shares
CY2013	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16978212	shares
CY2014Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18902783	shares
CY2014Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18902783	shares
CY2014Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18902783	shares
CY2014Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18904280	shares
CY2014	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18904280	shares
CY2015Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	21817710	shares
CY2015Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	24592883	shares
CY2015Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	28560211	shares
CY2015Q4	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29723254	shares
CY2015	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	26201713	shares
CY2015	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Concentration of Credit Risk</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Financial instruments that potentially subject the Company to significant concentrations of credit risk consist primarily of cash and cash equivalents. The Company maintains deposit accounts that are not insured by the Federal Deposit Insurance Corporation in federally insured financial institutions. The Company has not experienced any losses in such accounts and believes it is not exposed to significant risk on its cash due to the financial position of the depository institution in which those deposits are held.</font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"></font></div></div>
CY2015	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-style:italic;">Use of Estimates</font></div><div style="line-height:120%;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"> </font></div><div style="line-height:120%;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</font></div></div>

Files In Submission

Name	View Source	Status
0001628280-16-012562-index-headers.html	Edgar Link	pending
0001628280-16-012562-index.html	Edgar Link	pending
0001628280-16-012562.txt	Edgar Link	pending
0001628280-16-012562-xbrl.zip	Edgar Link	pending
corpperformancegrapha02.jpg	Edgar Link	pending
exhibit1028q42015.htm	Edgar Link	pending
exhibit1029q42015.htm	Edgar Link	pending
exhibit1030q42015.htm	Edgar Link	pending
exhibit1031q42015.htm	Edgar Link	pending
exhibit1032q42015.htm	Edgar Link	pending
exhibit21q42015.htm	Edgar Link	pending
exhibit231q42015.htm	Edgar Link	pending
exhibit311q42015.htm	Edgar Link	pending
exhibit312q42015.htm	Edgar Link	pending
exhibit321q42015.htm	Edgar Link	pending
exhibit322q42015.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
trov-123115x10k.htm	Edgar Link	pending
trov-20151231.xml	Edgar Link	completed
trov-20151231.xsd	Edgar Link	pending
trov-20151231_cal.xml	Edgar Link	unprocessable
trov-20151231_def.xml	Edgar Link	unprocessable
trov-20151231_lab.xml	Edgar Link	unprocessable
trov-20151231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CRDF
Cardiff Oncology, Inc. Stock $crdf

2015 Form 10-K Financial Statement

#000162828016012562 Filed on March 10, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF Cardiff Oncology, Inc. Stock $crdf

2015 Form 10-K Financial Statement

#000162828016012562 Filed on March 10, 2016

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CRDF
Cardiff Oncology, Inc. Stock $crdf